Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study-Reference-Cited by-同舟云学术

Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study

Published:2018-05-01 Issue:1 Volume:16 Page:
ISSN:1477-9560
Container-title:Thrombosis Journal
language:en
Short-container-title:Thrombosis J

Author:

Cohen Alexander T., ,Ay Cihan,Hainaut Philippe,Décousus Hervé,Hoffmann Ulrich,Gaine Sean,Coppens Michiel,da Silva Pedro Marques,Jiménez David,Amann-Vesti Beatrice,Brüggenjürgen Bernd,Levy Pierre,Bastida Julio Lopez,Vicaut Eric,Laeis Petra,Fronk Eva-Maria,Zierhut Wolfgang,Malzer Thomas,Bramlage Peter^ORCID,Agnelli Giancarlo

Funder

Daiichi Sankyo Europe GmbH, Munich, Germany

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1186/s12959-018-0163-7.pdf

Reference26 articles.

1. Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol. 2015;12:464–74.

2. Goldhaber SZ, Bounameaux H. Pulmonary embolism and deep vein thrombosis. Lancet. 2012;379:1835–46.

3. Cushman M, Tsai AW, White RH, Heckbert SR, Rosamond WD, Enright P, Folsom AR. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med. 2004;117:19–25.